首页 | 本学科首页   官方微博 | 高级检索  
     


p53 is an independent pre-treatment markers for long-term survival in stage II and III colorectal cancers: an analysis of interaction between genetic markers and fluorouracil-based adjuvant therapy
Authors:Tang Reiping  Wang Jeng-Yi  Fan Chung-Wei  Tsao Kuo-Chien  Chen Hong-Hua  Wu Chi-Ming  Chen Jinn-Shiun  Changchien Chung Rong  Hsieh Ling-Ling
Affiliation:Department of Colorectal Surgery, Chang Gung Memorial Hospital, Taipei, Taiwan, ROC.
Abstract:
One hundred and thirty-eight stage II and III colorectal cancer patients were included to evaluate the prognostic significance of genetic markers (including mutations of the p53, K-ras genes, and microsatellite instability) on the response to 5-fluorouracil (FU)-based post-operative adjuvant therapies (PAT). When stratified by PAT and adjusting for other prognostic variables, presence of p53 mutation was associated with a poor outcome (hazard ratio (HR)=3.1, 95% confidence interval (CI), 0.9-11.0) among patients without PAT. Our data confirmed that p53 mutation is an independent pre-treatment factor in stage II and III colorectal cancer after curative resection.
Keywords:
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号